Hisazumi H, Naito K, Uchibayashi T, Hirata A, Komatsu K
Department of Urology, School of Medicine, Kanazawa University, Japan.
Scand J Urol Nephrol Suppl. 1991;138:161-5.
Whole bladder wall photodynamic therapy using hematoporphyrin derivative and argon-dye laser light 630 nm was performed on 40 patients with mainly carcinoma in situ of the bladder. Two types of laser light scattering diffuser developed at our department were used: motor-driven and endoscope-modified laser light scattering diffusers. The total energy density used was 10 to 30 Joules/cm2. Of the 40 patients, 27 (67.5%) achieved complete response and 5 (12.5%) partial response at 3-months follow-up. In 11 of the 27 patients, there was no recurrence with an average tumor-free time of 26.3+/-26.1 months ranging from 3 to 75 months. Bladder capacity was reduced to approximately 150 ml for 3 months after treatment without any evidence of hydronephrosis or excretory urograms, except for 2 patients who had contracted bladders before treatment. The suitability of sulphonated AlCl phthalocyanine, a new photosensitizer to replace HpD, is discussed.
对40例主要为膀胱原位癌的患者采用血卟啉衍生物和630nm氩离子染料激光进行全膀胱壁光动力治疗。使用了我们科室研发的两种类型的激光散射扩散器:电动和经内镜改装的激光散射扩散器。使用的总能量密度为10至30焦耳/平方厘米。在40例患者中,27例(67.5%)在3个月随访时达到完全缓解,5例(12.5%)部分缓解。在27例患者中的11例,无复发,平均无瘤时间为26.3±26.1个月,范围为3至75个月。除2例治疗前膀胱已挛缩的患者外,治疗后3个月膀胱容量减少至约150ml,无任何肾积水或排泄性尿路造影的证据。讨论了新型光敏剂磺化铝酞菁替代血卟啉衍生物的适用性。